Published in Environ Health Perspect on April 01, 1996
Polychlorinated biphenyls (PCBs) and neurological development in children: a systematic review. J Epidemiol Community Health (2001) 1.10
Bias in analytic research. J Chronic Dis (1979) 16.40
Methylmercury poisoning in Iraq. Science (1973) 6.84
Impact of maternal seafood diet on fetal exposure to mercury, selenium, and lead. Arch Environ Health (1992) 3.16
Early diet in preterm babies and developmental status in infancy. Arch Dis Child (1989) 2.79
Fetal methylmercury poisoning. Relationship between concentration in single strands of maternal hair and child effects. Arch Neurol (1987) 1.69
Dose-response analysis of infants prenatally exposed to methyl mercury: an application of a single compartment model to single-strand hair analysis. Environ Res (1989) 1.43
Early neurotoxic effects of occupational lead exposure: a prospective study. Neurotoxicology (1983) 1.30
Milestone development in infants exposed to methylmercury from human milk. Neurotoxicology (1995) 1.17
Neurobehavioral effects of intrauterine mercury exposure: potential sources of bias. Environ Res (1993) 1.09
Human milk as a source of methylmercury exposure in infants. Environ Health Perspect (1994) 1.08
The effect of ethanol on the fate of mercury vapor inhaled by man. J Pharmacol Exp Ther (1980) 0.98
Mercury in the Umbilical Cord: Implications for Risk Assessment for Minamata Disease. Environ Health Perspect (1994) 0.91
Non-specificity of clinical signs and symptoms caused by environmental chemicals. Hum Exp Toxicol (1991) 0.87
Reference intervals for trace elements in blood: significance of risk factors. Scand J Clin Lab Invest (1992) 0.87
Epidemiologic approaches to assessing the developmental toxicity of lead. Neurotoxicology (1994) 0.85
Interaction of ethanol and inorganic mercury: generation of mercury vapor in vivo. J Pharmacol Exp Ther (1981) 0.83
Evaluation of mercury in hair, blood and muscle as biomarkers for methylmercury exposure in male and female mice. Arch Toxicol (1994) 0.80
Comparative study of the sensitivity of male and female rats to methylmercury. Arch Toxicol (1981) 0.80
Sister chromatid exchange in response to variations in occupational lead exposure. Environ Res (1983) 0.79
Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol (1997) 8.51
The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol (2000) 4.77
Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke (1997) 3.26
Impact of maternal seafood diet on fetal exposure to mercury, selenium, and lead. Arch Environ Health (1992) 3.16
Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke (1998) 3.03
Maternal seafood diet, methylmercury exposure, and neonatal neurologic function. J Pediatr (2000) 3.03
Neurobehavioral deficits associated with PCB in 7-year-old children prenatally exposed to seafood neurotoxicants. Neurotoxicol Teratol (2001) 2.85
Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 years. Am J Epidemiol (1999) 2.41
Tumor necrosis factor-alpha expression in ischemic neurons. Stroke (1994) 2.37
Birthweight in a fishing community: significance of essential fatty acids and marine food contaminants. Int J Epidemiol (2001) 2.17
Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology (1996) 2.00
Prenatal methylmercury exposure as a cardiovascular risk factor at seven years of age. Epidemiology (1999) 1.86
Methylmercury neurotoxicity in Amazonian children downstream from gold mining. Environ Health Perspect (1999) 1.85
Relation of a seafood diet to mercury, selenium, arsenic, and polychlorinated biphenyl and other organochlorine concentrations in human milk. Environ Res (1995) 1.56
Occupational lead neurotoxicity: improvement in behavioural effects after reduction of exposure. Br J Ind Med (1985) 1.55
Cognitive performance of children prenatally exposed to "safe" levels of methylmercury. Environ Res (1998) 1.54
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther (2001) 1.54
Frequency of seafood intake in pregnancy as a determinant of birth weight: evidence for a dose dependent relationship. J Epidemiol Community Health (1993) 1.46
Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J Neurosci Res (1991) 1.45
Health status of Persian Gulf War veterans: self-reported symptoms, environmental exposures and the effect of stress. Int J Epidemiol (1998) 1.36
Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study. Brain Res Bull (1993) 1.33
Interleukin-1 beta mRNA expression in ischemic rat cortex. Stroke (1993) 1.30
Betaine-homocysteine transmethylase in Pseudomonas denitrificans, a vitamin B 12 overproducer. J Bacteriol (1973) 1.29
Evidence of presymptomatic cognitive decline in Huntington's disease. J Clin Exp Neuropsychol (1992) 1.27
Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol (1995) 1.26
Late onset of Huntington's disease. J Neurol Neurosurg Psychiatry (1985) 1.18
Milestone development in infants exposed to methylmercury from human milk. Neurotoxicology (1995) 1.17
Catabolism of betaine and its relationship to cobalamin overproduction. Biochim Biophys Acta (1971) 1.17
Influenza vaccination in community elderly. A controlled trial of postcard reminders. J Am Geriatr Soc (1987) 1.17
Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27. Brain Res (2000) 1.16
Isolation of Lyme disease Borrelia from puffins (Fratercula arctica) and seabird ticks (Ixodes uriae) on the Faeroe Islands. J Clin Microbiol (1999) 1.15
Genetic hypertension and increased susceptibility to cerebral ischemia. Neurosci Biobehav Rev (1992) 1.13
Evoked potentials in Faroese children prenatally exposed to methylmercury. Neurotoxicol Teratol (1999) 1.13
Benchmark dose calculations of methylmercury-associated neurobehavioural deficits. Toxicol Lett (2000) 1.12
Methylmercury: significance of intrauterine and postnatal exposures. Clin Chem (1994) 1.11
Specificity of the stimulatory effect of betaine on the vitamin B12 fermentation. Nature (1968) 1.10
Neurobehavioral effects of intrauterine mercury exposure: potential sources of bias. Environ Res (1993) 1.09
Relationship of psychiatric status to Gulf War veterans' health problems. Psychosom Med (1999) 1.08
Methylmercury dose estimation from umbilical cord concentrations in patients with Minamata disease. Environ Res (1998) 1.08
Human milk as a source of methylmercury exposure in infants. Environ Health Perspect (1994) 1.08
Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue. Brain Res Bull (1994) 1.06
Brain cooling during transient focal ischemia provides complete neuroprotection. Neurosci Biobehav Rev (1997) 1.06
Asymptomatic sequelae to acute sarin poisoning in the central and autonomic nervous system 6 months after the Tokyo subway attack. J Neurol (1997) 1.06
SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia. Brain Res (2001) 1.06
Feasibility and validity of three computer-assisted neurobehavioral tests in 7-year-old children. Neurotoxicol Teratol (1997) 1.06
Changes with time in the distribution of virus and PR protein around single local lesions of TMV infected tobacco. Plant Mol Biol (1986) 1.05
Delayed evoked potentials in children exposed to methylmercury from seafood. Neurotoxicol Teratol (1999) 1.04
Endothelin levels increase in rat focal and global ischemia. J Cereb Blood Flow Metab (1994) 1.02
Effect of overtime work on cognitive function in automotive workers. Scand J Work Environ Health (1996) 1.01
The chemical induction of PR (b) proteins and resistance to TMV infection in tobacco. Antiviral Res (1986) 1.00
Porphyrin overproduction by Pseudomonas denitrificans: essentiality of betaine and stimulation by ethionine. J Bacteriol (1971) 1.00
Sleep abnormalities in progressive supranuclear palsy. Ann Neurol (1989) 0.97
Methylmercury neurotoxicity independent of PCB exposure. Environ Health Perspect (1999) 0.95
Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia. Stroke (1992) 0.94
Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia. Brain Res (1993) 0.93
Monitoring neurotoxins in industry: development of a neurobehavioral test battery. J Occup Med (1983) 0.93
Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. Proc Natl Acad Sci U S A (1995) 0.93
Transforming growth factor-beta 1 exhibits delayed gene expression following focal cerebral ischemia. Brain Res Bull (1995) 0.93
Impact of contrast sensitivity performance on visually presented neurobehavioral tests in mercury-exposed children. Neurotoxicol Teratol (2001) 0.93
The diagnostic utility of savings scores: differentiating Alzheimer's and Huntington's diseases with the logical memory and visual reproduction tests. J Clin Exp Neuropsychol (1993) 0.93
A behavioral evaluation of PCE exposure in patients and dry cleaners: a possible relationship between clinical and preclinical effects. J Occup Environ Med (1995) 0.92
Isolation and characterization of a cDNA clone encoding the anti-viral protein from Phytolacca americana. Plant Mol Biol (1991) 0.92
The role of occupational lead exposure in the genesis of psychiatric and behavioral disturbances. Acta Psychiatr Scand Suppl (1983) 0.92
Chronic neurobehavioral effects of Tokyo subway sarin poisoning in relation to posttraumatic stress disorder. Arch Environ Health (1998) 0.91
Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia. Neurosci Lett (1993) 0.89
Distribution of the ppp(A2'p)nA-binding protein and interferon-related enzymes in animals, plants, and lower organisms. Biochem Biophys Res Commun (1982) 0.89
Leukapheresis of patients with chronic granulocytic leukemia (CGL), using the Haemonetics blood processor. Transfusion (1976) 0.88
Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke. Mol Chem Neuropathol (1995) 0.87
Microbial epoxidation of cis-propenylphosphonic to (-)-cis-1,2-epoxypropylphosphonic acid. Appl Microbiol (1971) 0.87
Concomitant administration of granulocyte transfusions and amphotericin B in neutropenic patients: absence of significant pulmonary toxicity. Blood (1981) 0.86
[Computer assisted neuropsychological testing of children]. Ugeskr Laeger (1998) 0.86
Health-related quality of life in Persian Gulf War Veterans. Mil Med (2001) 0.85
Trimethyltin encephalopathy. Arch Neurol (1993) 0.83
Validity of a computer-assisted neurobehavioral test battery in toxicant encephalopathy. Neurotoxicology (2000) 0.83
Gold colitis. Med J Aust (1983) 0.83
Use of diffusion-weighted MRI and neurological deficit scores to demonstrate beneficial effects of isradipine in a rat model of focal ischemia. Pharmacology (1999) 0.83
Observation of muon neutrino disappearance with the MINOS detectors in the NuMI neutrino beam. Phys Rev Lett (2006) 0.81
Screening for complement deficiencies in patients surviving from epidemic meningococcal disease. J Clin Lab Immunol (1988) 0.81
A case-control study of chronic neuropsychiatric disease and organic solvent exposure in automobile assembly plant workers. Occup Environ Med (1994) 0.80
Long-term follow-up after single toxic exposure to trichloroethylene. Am J Ind Med (1985) 0.80
Football training improves cardiovascular health profile in sedentary, premenopausal hypertensive women. Scand J Med Sci Sports (2014) 0.80
Acute stroke therapy: translating preclinical neuroprotection to therapeutic reality. Curr Opin Investig Drugs (2000) 0.80
The protein and nucleic acid of beet yellows virus. Virology (1977) 0.79
Failure of cholinergic agonist RS-86 to improve cognition and movement in PSP despite effects on sleep. Neurology (1989) 0.79
Chemical sensitivity and chronic fatigue in Gulf War veterans: a brief report. J Occup Environ Med (2001) 0.78
The endothelin receptor antagonist SB 217242 reduces cerebral focal ischemic brain injury. J Cardiovasc Pharmacol (1995) 0.78
Subtractive cloning identifies tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) increased gene expression following focal stroke. Stroke (1998) 0.78
Microbial transformation of L-696,474, a novel cytochalasin as an inhibitor of HIV-1 protease. J Nat Prod (1993) 0.78
Prevalence and incidence of Parkinson's disease in The Faroe Islands. Acta Neurol Scand (2008) 0.78